AgelessRx vs Gatlan
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
AgelessRx
Best for longevity-focused GLP-1 care (pending verification)Starting at $199/mo
Gatlan
Best for Buyers seeking a named-clinical-leadership GLP-1 platform with Dr. Robert Lufkin (UCLA/USC) as Chief Medical Advisor, who value verifiable academic credentials over anonymous DTC marketplace framing, and who live in one of the 44 covered states. Strong fit for premium-clinical-attention buyers who are comfortable with pricing gated behind sign-up.Side-by-Side Comparison
| Feature | AgelessRx | Gatlan |
|---|---|---|
| Overall Score | ✓7.1/10 | 6.9/10 |
| Starting Price | $199/mo | — |
| Editorial Rating | ✓3.6 ★ /5 | 3.5 ★ /5 |
| Features | 6 features | ✓8 features |
| States Available | 0 | ✓44 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
AgelessRx
Pros
- ✓Established brand based in Ann Arbor, MI with US-licensed providers
- ✓Offers both compounded and brand-name (Wegovy) options
- ✓Longevity-first positioning — patients get a broader metabolic health framing vs single-condition GLP-1 funnels
- ✓Listed in both competitor directories
Cons
- ✗Stub entry — pricing, states served, and GLP-1-specific intake workflow need YMYL verification
- ✗Confidence LOW until verified
- ✗Longevity-first positioning means GLP-1 is one of several products — patients looking specifically for GLP-1 care may be funneled into a broader longevity intake
Gatlan
Pros
- ✓**Named Chief Medical Advisor with verifiable credentials** — Dr. Robert Lufkin (UCLA/USC School of Medicine Professor) is genuinely uncommon transparency vs the DTC GLP-1 market where most platforms hide clinical leadership behind 'team of licensed providers' generic framing. Verifiable academic credential.
- ✓44-state explicit enumeration with named states — buyers can directly confirm coverage for their state without navigating to a sign-up flow
- ✓'Doctor-Level Care, Minus the Friction' positioning targets buyers who want premium clinical attention vs marketplace-platform feel
- ✓100% online process with concierge delivery & monitoring framing
- ✓Tirzepatide compounded confirmed via customer testimonial
Cons
- ✗Specific pricing NOT disclosed on the public homepage — fully gated behind sign-up flow
- ✗Whether compounded SEMAGLUTIDE is also offered (alongside tirzepatide) is unclear — only tirzepatide is mentioned in the indexable homepage content
- ✗LegitScript certification status NOT disclosed
- ✗Specific 503A/503B pharmacy partner NOT named
- ✗503A vs 503B compounding designation NOT specified
- ✗Verbatim FDA compounded-medication disclaimer NOT published on the homepage
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed
- ✗Corporate physical address NOT disclosed
- ✗Governing law / arbitration venue NOT disclosed
- ✗Refund / cancellation policy NOT publicly detailed
- ✗7 states excluded (AK, AR, MA, NM, OR, RI, SC) — buyers in those states are not eligible
Our Verdict
AgelessRx edges out Gatlan with a higher overall score of 7.1/10 and is particularly strong for longevity-focused GLP-1 care (pending verification). Gatlan remains a solid alternative, especially if you're looking for Buyers seeking a named-clinical-leadership GLP-1 platform with Dr. Robert Lufkin (UCLA/USC) as Chief Medical Advisor, who value verifiable academic credentials over anonymous DTC marketplace framing, and who live in one of the 44 covered states. Strong fit for premium-clinical-attention buyers who are comfortable with pricing gated behind sign-up..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.